IDiyas

For the Inventor, By the Inventor

Sudbury, MA, United States of America

Edward R Lee

USPTO Granted Patents = 30 

 

Average Co-Inventor Count = 6.4

ph-index = 13

Forward Citations = 692(Granted Patents)


Location History:

  • Lincoln Heights, MA (US) (1999)
  • Quincy, MA (US) (1997 - 2000)
  • Natick, MA (US) (1999 - 2002)
  • Sudbury, MA (US) (2012 - 2019)

Company Filing History:

goldMedal25 out of 787 
 
Genzyme Corporation
 patents
silverMedal4 out of 11 
 
Placon Therapeutics, Inc.
 patents
bronzeMedal1 out of 902 
 
University of Iowa Research Foundation
 patents
4. 1 out of 8 
 
Tarveda Therapeutics, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1997-2019

Loading Chart...
Loading Chart...
30 patents (USPTO):
1. 10472380 - Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof (2019-11-12),
2. 10111853 - Compounds, compositions, and methods for the treatment of cancers (2018-10-30),
3. 9771387 - Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof (2017-09-26),
4. 9745294 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2017-08-29),
5. 9744153 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2017-08-29),
6. 9556214 - Compounds, compositions, and methods for the treatment of cancers (2017-01-31),
7. 9480657 - Cabazitaxel-platinum nanoparticles and methods of using same (2016-11-01),
8. 9272996 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2016-03-01),
9. 8940776 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2015-01-27),
10. 8309593 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2012-11-13),
11. 8304447 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2012-11-06),
12. 6383814 - Cationic amphiphiles for intracellular delivery of therapeutic molecules (2002-05-07),
13. 6331524 - Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy (2001-12-18),
14. 6323191 - Small molecule chloride transport (2001-11-27),
15. 6071890 - Organ-specific targeting of cationic amphiphile/DNA complexes for gene (2000-06-06),

Title: Spotlight on Inventor Edward R Lee from Sudbury, MA

Introduction: Meet Edward R Lee, a prolific inventor from Sudbury, MA, with an impressive portfolio of 30 patents to his name. His innovative work has made significant contributions to the field of cancer treatment and beyond.

Latest Patents:

1. "Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof" - This patent introduces novel platinum compositions with a heterocycle ligand and nanoparticles for treating cancer.

2. "Compounds, compositions, and methods for the treatment of cancers" - The patent explores compounds and compositions, including a platinum (IV) complex with carboxylate or carbamate ligands, for cancer treatment.

Career Highlights: Edward R Lee has shared his expertise with notable companies such as Genzyme Corporation and Placon Therapeutics, Inc. His innovative mindset and dedication have left a lasting impact on the industry.

Collaborations: Throughout his career, Edward R Lee has collaborated with esteemed professionals like David J Harris and Craig S Siegel. Together, they have worked on cutting-edge projects that have pushed the boundaries of innovation.

Conclusion: Edward R Lee's groundbreaking work in the development of cancer treatment technologies showcases his commitment to improving healthcare outcomes. His collaborations with industry experts reflect his collaborative spirit and drive for excellence. Sudbury, MA is proud to be home to such a talented inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…